Back to top
more

ViewRay, Inc. (VRAY)

(Delayed Data from NSDQ)

$4.21 USD

4.21
1,302,101

+0.06 (1.45%)

Updated Mar 5, 2021 04:00 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.41%
2Buy17.88%
3Hold9.48%
4Sell5.03%
5Strong Sell1.87%
S&P50010.70%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth C Momentum F VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (174 out of 254)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for VRAY More Info

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for ViewRay, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents NA 227 167 57 14
Receivables NA 17 37 20 4
Notes Receivable NA 0 0 0 0
Inventories NA 55 49 19 8
Other Current Assets NA 13 24 26 9
Total Current Assets NA 312 278 123 36
Net Property & Equipment NA 23 14 12 12
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 0 0 0 0
Deposits & Other Assets NA 3 3 1 1
Total Assets NA 350 295 136 49
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable NA 0 0 0 0
Accounts Payable NA 14 10 11 5
Current Portion Long-Term Debt NA 2 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 21 10 7 6
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 20 34 38 26
Total Current Liabilities NA 59 54 56 37
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 4 6 3 4
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 54 55 45 44
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 1 1 7 4
Minority Interest (Liabilities) NA 5 12 22 3
Total Liabilities NA 134 128 134 92
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 0
Capital Surplus NA 734 565 321 204
Retained Earnings NA -519 -399 -320 -248
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 216 167 2 -44
Total Liabilities & Shareholder's Equity NA 350 295 136 49
Total Common Equity 0 216 167 2 -44
Shares Outstanding 148.50 147.10 95.70 67.50 43.40
Book Value Per Share 0.00 1.47 1.75 0.03 -1.01

Fiscal Year End for ViewRay, Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Assets          
Cash & Equivalents NA 164 180 190 227
Receivables NA 27 22 21 17
Notes Receivable NA 0 0 0 0
Inventories NA 46 48 55 55
Other Current Assets NA 18 16 14 13
Total Current Assets NA 255 266 280 312
Net Property & Equipment NA 23 23 24 23
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 0 0 0 0
Deposits & Other Assets NA 3 4 4 3
Total Assets NA 290 303 319 350
Liabilities & Shareholders Equity 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Notes Payable NA 0 0 0 0
Accounts Payable NA 8 5 7 14
Current Portion Long-Term Debt NA 16 11 6 2
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 18 17 16 21
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 38 33 26 20
Total Current Liabilities NA 81 68 58 59
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 3 3 3 4
Convertible Debt NA 0 0 3 0
Long-Term Debt NA 40 45 49 54
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 2 2 1
Minority Interest (Liabilities) NA 4 2 0 5
Total Liabilities NA 139 129 125 134
Shareholders Equity 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 751 745 739 734
Retained Earnings NA -601 -573 -547 -519
Other Equity NA 0 0 0 0
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 151 174 194 216
Total Liabilities & Shareholder's Equity NA 290 303 319 350
Total Common Equity 0 151 174 194 216
Shares Outstanding 148.50 148.50 147.90 147.40 147.10
Book Value Per Share 0.00 1.02 1.18 1.32 1.47